

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Prev… read more
-
ETF
Equity
- years
45 holdings
$35.93
Price-0.09%
-$0.03
$56.439m
Small
$27.924k
Avg Volume$81.704m
$33.05
NAV0.75%
Expense Ratio1.31%
Yield$0.47
Dividend